Top of the morning to you. And another fine one, it is. The sun is shining, the Pharmalot campus is blissfully quiet and more cups of stimulation are brewing in the Pharmalot cafeteria. All of which means that we are in the midst of yet another busy day. No doubt, you can relate. So time to dig in to the usual routine and, to help you along, we have assembled a few items of interest. Good luck, today, and of course, do keep in touch…
Theranos ceo Elizabeth Holmes plans to release a 16-page point-by-point rebuttal to articles in The Wall Street Journal that questioned the accuracy of its blood tests and the extent to its unique technology is used; Oh, say, can you see? An Illinois businessman is angry because his display of patriotism was removed from ads for a new cancer drug that are being run by Bristol-Myers Squibb; and Gilead Sciences is now known to be developing an experimental drug for Ebola after a London hospital revealed that the treatment had been given to a nurse who had been readmitted with the illness.